Quick answers
- What is Sandostatin?
- Sandostatin is a brand name of Octreotide acetate, a prescription medicine. The FDA NDC Directory lists 3 Sandostatin products in 3 strengths and forms.
- Who makes Sandostatin?
- Novartis holds the FDA application for Sandostatin (NDA019667, approved October 21, 1988).
- Is there a generic or store brand of Sandostatin?
- Yes. The FDA NDC Directory lists 19 other products with the same active ingredients, strength and form as a Sandostatin product, 19 of them generic. Ask your pharmacist whether one is right for you.
- Has Sandostatin been recalled?
- No recall linked to Sandostatin products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Sandostatin is
Each Sandostatin product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Octreotide acetate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| octreotide acetate 100 ug/mL injection, solution (intravenous, subcutaneous) | Sandostatin | 8 products, 8 companies | DailyMed |
| octreotide acetate 50 ug/mL injection, solution (intravenous, subcutaneous) | Sandostatin | 4 products, 4 companies | DailyMed |
| octreotide acetate 500 ug/mL injection, solution (intravenous, subcutaneous) | Sandostatin | 7 products, 7 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Octreotide acetate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
| Application | Holder | First approved | Products |
|---|---|---|---|
| NDA019667 | Novartis | October 21, 1988 | 3 |
Companies that list Sandostatin
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Sandostatin products.
- Novartis Pharmaceuticals Corporation3 products
Recalls
No recall linked to Sandostatin products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.